LLY

Eli Lilly and Company (LLY)

US
$ 751.45-3.25%

Price Chart

Key Statistics

Market Cap
$ 737.66B
P/E Ratio
66.95
Revenue (TTM)
$ 49B
Volume
6.12M
52W High
$ 969.25
52W Low
$ 677.09
Dividend Yield
0.73%
Beta
0.47

Technicals

50-Day MA
832.248
200-Day MA
843.2544
52 Week High
969.2515
52 Week Low
677.0912

About LLY

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, H.

Employees
47000
Headquarters
Indianapolis, IN
CEO
Mr. David A. Ricks

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score
32.36
Percentile: 70.22
Environmental Risk Score
0.63
Percentile: 1
Social Risk Score
16.68
Percentile: 1
Governance Risk Score
13.31
Percentile: 1

Controversy Level

ESG data provided by Sustainalytics, Inc.

LLY
Category Average
3Significant Controversy Level
NoneSevere

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg